Harrow (HROW) Capital Expenditures (2012 - 2026)
Harrow (HROW) recorded quarterly Capital Expenditures of $194000.0 in Q1 2026, down 43.11% quarter-over-quarter from $341000.0 in Q4 2025, and up 14.12% on a YoY basis from $170000.0 in Q1 2025.
Harrow (HROW) Capital Expenditures (2012 - 2026) Analysis & Trends
Harrow's Capital Expenditures history runs 15 years deep, the most recent figure standing at $194000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 14.12% year-over-year to $194000.0; the TTM figure through Mar 2026 stood at $911000.0 (up 472.96% YoY), while the FY2025 annual figure was $887000.0, up 995.06% from the prior year.
- Capital Expenditures was $194000.0 for Q1 2026 at Harrow, down from $341000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q3 2023 to a low of -$959000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $307000.0 across 5 years, with a median of $260000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 540.88% in 2022, then sank 594.33% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $878000.0 in 2022, then tumbled by 77.9% to $194000.0 in 2023, then tumbled by 594.33% to -$959000.0 in 2024, then soared by 135.56% to $341000.0 in 2025, then tumbled by 43.11% to $194000.0 in 2026.
- The last three Capital Expenditures figures came in at $194000.0 (Q1 2026), $341000.0 (Q4 2025), and $210000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 194,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | -959,000.00 |
| Dec 31, 2024 | -959,000.00 |
| Sep 30, 2024 | 604,000.00 |
| Sep 30, 2024 | 604,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 194,000.00 |
| Dec 31, 2023 | 194,000.00 |